Gender differences in the clinical course of Finnish gelsolin amyloidosis

References

• Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1969;1:314–24
   PubMedGoogle Scholar
• Kiuru-Enari S, Haltia M. Hereditary gelsolin amyloidosis. Peripheral nerve disorders, volume 115. In: Said G, Krarup C, eds. Handbook of clinical neurology. Amsterdam: Elsevier; 2013:659–81
   Google Scholar
• Solomon JP, Page LJ, Balch WE, Kelly JW. Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Crit Rev Biochem Mol Biol 2012;47:282–96
   PubMed Web of Science ®Google Scholar
• Haltia M, Levy E, Meretoja J, Fernandez-Madrid I, Koivunen O, Frangione B. Gelsolin gene mutation – at codon 187 – in familial amyloidosis, Finnish: DNA-diagnostic assay. Am J Med Genet 1992;42:357–9
   PubMed Web of Science ®Google Scholar
• Chen CD, Huff ME, Matteson J, Page L, Phillips R, Kelly JW, Balch WE. Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilization. EMBO J 2001;20:6277–87
   PubMed Web of Science ®Google Scholar
• Page LJ, Suk JY, Huff ME, Lim HJ, Venable J, Yates J, Kelly JW, et al Metalloendoprotease cleavage triggers gelsolin amyloidogenesis. EMBO J 2005;24:4124–32
   PubMed Web of Science ®Google Scholar
• Page LJ, Suk JY, Bazhenova L, Fleming SM, Wood M, Jiang Y, Guo LT, et al Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins. Proc Natl Acad Sci USA 2009;106:11125–30
   PubMed Web of Science ®Google Scholar
• Van Overbeke W, Verhelle A, Everaert I, Zwaenepoel O, Vandekerckhove J, Cuvelier C, Derave W, et al Chaperone nanobodies protect gelsolin against MT1-MMP degradation and alleviate amyloid burden in the gelsolin amyloidosis mouse model. Mol Ther 2014;22:1768–78
   PubMed Web of Science ®Google Scholar
• Van Overbeke W, Wongsantichon J, Everaert I, Verhelle A, Zwaenepoel O, Loonchanta A, Burtnick LD, et al An ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse model. Hum Mol Genet 2015;24:2492–507
   PubMed Web of Science ®Google Scholar
• Mattila JS, Krootila K, Kivelä T, Holopainen JM. Penetrating keratoplasty for corneal amyloidosis in familial amyloidosis, Finnish type. Ophthalmology 2015;122:457–63
   PubMed Web of Science ®Google Scholar
• Kiuru-Enari S, Somer H, Seppäläinen AM, Notkola IL, Haltia M. Neuromuscular pathology in hereditary gelsolin amyloidosis. J Neuropathol Exp Neurol 2002;61:565–71
   PubMed Web of Science ®Google Scholar
• Kiuru-Enari S, Keski-Oja J, Haltia M. Cutis laxa in hereditary gelsolin amyloidosis. Br J Dermatol 2005;152:250–7
   PubMed Web of Science ®Google Scholar
• Pihlamaa T, Rautio J, Kiuru-Enari S, Suominen S. Gelsolin amyloidosis as a cause of early aging and progressive bilateral facial paralysis. Plast Reconstr Surg 2011;127:2342–51
   PubMed Web of Science ®Google Scholar
• Bornebroek M, Westendorp RG, Haan J, Bakker E, Timmers WF, Van Broeckhoven C, Roos RA. Mortality from hereditary cerebral haemorrhage with amyloidosis – Dutch type. The impact of sex, parental transmission and year of birth. Brain 1997;120:2243–9
   PubMed Web of Science ®Google Scholar
• Ordóñez-Gutiérrez L, Antón M, Wandosell F. Peripheral amyloid levels present gender differences associated with aging in AβPP/PS1 mice. J Alzheimers Dis 2015;44:1063–8
   PubMed Web of Science ®Google Scholar
• González-Duarte A, Soto KC, Martínez-Baños D, Arteaga-Vazquez J, Barrera F, Berenguer-Sanchez M, Cantu-Brito C, et al Familial amyloidosis with polyneuropathy associated with TTR Ser50Arg mutation. Amyloid 2012;19:171–6
   PubMed Web of Science ®Google Scholar
• Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005;165:1425–9
   PubMed Web of Science ®Google Scholar
• Kiuru S. Familial amyloidosis, Finnish type: clinical, histological and amyloid protein studies [dissertation]. Helsinki: University of Helsinki; 1995
   Google Scholar
• Juusela P, Tanskanen M, Nieminen A, Uitto VJ, Blåfield H, Kiuru-Enari S. Hereditary gelsolin amyloidosis mimicking Sjögren's syndrome. Clin Rheumatol 2009;28:1351–4
   PubMed Web of Science ®Google Scholar
• Hiltunen T, Kiuru S, Hongell V, Heliö T, Palo J, Peltonen L. Finnish type of familial amyloidosis: cosegregation of Asp187-Asn mutation of gelsolin with the disease in three large families. Am J Hum Genet 1991;49:522–8
   PubMed Web of Science ®Google Scholar
• Carrwik C, Stenevi U. Lattice corneal dystrophy, gelsolin type (Meretoja's syndrome). Acta Ophthalmol 2009;87:813–19
   PubMed Web of Science ®Google Scholar
• Kivelä T, Tarkkanen A, Frangione B, Ghiso J, Haltia M. Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome. Invest Ophthalmol Vis Sci 1994;35:3759–69
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Uchiyama S, Tojo K, Sano K, Shimizu Y, Imaeda T, Hoshii Y, et al High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly. Hum Pathol 2011;42:1785–91
   PubMed Web of Science ®Google Scholar
• Li R, Singh M. Sex differences in cognitive impairment and Alzheimer's disease. Front Neuroendocrinol 2014;35:385–403
   PubMed Web of Science ®Google Scholar